Thus, the DCIS samples were categorised as luminal A (ER+/PR+/Her−), luminal B (ER+PR+ or PR−/Her 2+), Her 2 (ER−/PR−/Her2+) and triple negative (TN; ER−/PR−/Her2−). This evidence concerns the gene PGR and ductal breast carcinoma in situ.